Target
Apoptosis regulator Bcl-2
Ligand
BDBM608701
Substrate
n/a
Meas. Tech.
BCL-2 TR-FRET Assay
IC50
30±n/a nM
Citation
 Kysil, VParchinsky, VZPushechnikov, AIvachtchenko, AVAbagyan, ROrry, ALam, PCSavchuk, N Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors US Patent  US11697650 Publication Date 7/11/2023
Target
Name:
Apoptosis regulator Bcl-2
Synonyms:
Apoptosis regulator Bcl-2 Protein | B-cell lymphoma 2 protein (Bcl-2) | BCL-2 | BCL2 | BCL2_HUMAN | Bcl-2 Protein
Type:
Homodimer or heterodimer
Mol. Mass.:
26269.11
Organism:
Homo sapiens (Human)
Description:
P10415
Residue:
239
Sequence:
MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK
  
Inhibitor
Name:
BDBM608701
Synonyms:
US11697650, Compound 32 | US11697650, Example 10
Type:
Small organic molecule
Emp. Form.:
C45H45FN4O6
Mol. Mass.:
756.8604
SMILES:
Cc1cccc(F)c1CN(C(=O)c1cc(-c2cc3OCOc3cc2C(=O)N2Cc3ccccc3C[C@H]2CN2CCOCC2)n2CCCCc12)c1ccc(O)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: